The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation
Open Access
- 22 February 2005
- journal article
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 20 (2), 93-100
- https://doi.org/10.1093/mutage/gei012
Abstract
Cytochrome b5 (b5) is increasingly recognized to be of importance for specific cytochrome P450 (CYP) activities. We developed human b5/CYP-competent mutagenicity tester bacteria to study the role of b5 in the bioactivation activity of human CYP. These new tester bacteria were derived from the previously engineered human CYP-competent Escherichia coli K12 tester strain MTC, containing a bi-plasmid system for the co-expression of a specific CYP form (CYP1A2, 2A6 or 2E1) with human b5, and human NADPH cytochrome P450 reductase (RED), resulting in the strain BTC-b5-1A2, BTC-b5-2A6 and BTC-b5-2E1, respectively. The relative content of b5 with CYP and RED in these three BTC-b5-CYP strains demonstrated physiologically relevant co-expression levels and typical CYP-specific activities could be determined with their specific chemical probes. These strains were applied in mutagenicity assays along with their corresponding b5-void strains to determine the effect of b5 on the CYP1A2-, CYP2A6- and CYP2E1-mediated bioactivation of several promutagens. For CYP1A2, of the 5 compounds tested [2-aminoanthracene (2AA), 1-aminopyrene, 6-aminochrysene, 2-amino-3-methylimidazo(4,5-f)quinoline and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)], only the mutagenicity of 2AA was slightly increased (∼1.5-fold) in the presence of b5. The CYP2E1- and CYP2A6-dependent mutagenicity of N-nitrosodiethylamine increased ∼3- and 23-fold, respectively when the bacteria contained b5. The CYP2A6-mediated mutagenicity of NNK increased ∼9-fold when co-expressed with b5. The stimulatory effect of b5 on the bioactivation of N-nitrosodi-n-propylamine was most striking. The mutagenicity of this procarcinogen was completely dependent on the co-expression of b5 with CYP2A6 or CYP2E1. This demonstrates the prominent role of b5 in the bioactivation of this carcinogen.Keywords
This publication has 25 references indexed in Scilit:
- Inactivation of the Hepatic Cytochrome P450 System by Conditional Deletion of Hepatic Cytochrome P450 ReductaseJournal of Biological Chemistry, 2003
- Roles of NADPH-P450 Reductase and Apo- and Holo-Cytochrome b5 on Xenobiotic Oxidations Catalyzed by 12 Recombinant Human Cytochrome P450s Expressed in Membranes of Escherichia coliProtein Expression and Purification, 2002
- Genetic susceptibility to adverse effects of drugs and environmental toxicants: The role of the CYP family of enzymesMutation Research, 2001
- Stimulation of Cytochrome P450 Reactions by Apo-cytochromeb 5Journal of Biological Chemistry, 2001
- Heterologous Expression of Xenobiotic Mammalian-Metabolizing Enzymes in Mutagenicity Tester Bacteria: An Update and Practical ConsiderationsCritical Reviews in Toxicology, 2000
- Effects of Human Cytochrome b5on CYP3A4 Activity and Stabilityin VivoArchives of Biochemistry and Biophysics, 1999
- The Environmental Genome Project: functional analysis of polymorphisms.Environmental Health Perspectives, 1998
- MX100, a new Escherichia coli tester strain for use in genotoxicity studiesMutagenesis, 1996
- Effects of Freezing, Thawing, and Storing Human Liver Microsomes on Cytochrome P450 ActivityArchives of Biochemistry and Biophysics, 1996
- Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomesBiochemical Pharmacology, 1996